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Abstract
Aneuploidy and chromosomal instability (CIN) are hallmarks of most solid tumors. These alterations may result from
inaccurate chromosomal segregation during mitosis, which can occur through several mechanisms including defec-
tive telomere metabolism, centrosome amplification, dysfunctional centromeres, and/or defective spindle check-
point control. In this work, we used an in vitro murine melanoma model that uses a cellular adhesion blockade as
a transforming factor to characterize telomeric and centromeric alterations that accompany melanocyte transforma-
tion. To study the timing of the occurrence of telomere shortening in this transformation model, we analyzed the
profile of telomere length by quantitative fluorescent in situ hybridization and found that telomere length significantly
decreased as additional rounds of cell adhesion blockages were performed. Together with it, an increase in telomere-
free ends and complex karyotypic aberrations were also found, which include Robertsonian fusions in 100% of
metaphases of the metastatic melanoma cells. These findings are in agreement with the idea that telomere length
abnormalities seem to be one of the earliest genetic alterations acquired in the multistep process of malignant trans-
formation and that telomere abnormalities result in telomere aggregation, breakage-bridge-fusion cycles, and CIN.
Another remarkable feature of this model is the abundance of centromeric instability manifested as centromere frag-
ments and centromeric fusions. Taken together, our results illustrate for this melanoma model CIN with a structural
signature of centromere breakage and telomeric loss.
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Introduction
The progression of a melanocyte to malignant melanoma is a multi-
step process requiring the gradual acquisition of genetic and epigenetic
alterations. This transformation process is characterized by the loss of
tumor-suppressor genes, epigenetic changes, alterations of the mis-
match repair pathway, and the generation of genomic instability [1].
Malignant melanomas commonly display two types of genomic insta-
bility found in cancer, microsatellite instability and chromosomal insta-
bility (CIN). Microsatellite instability is found in approximately 30%
of cases, whereas CIN is associated with most cases analyzed [1–3].
CIN is a hallmark of most classes of solid tumors [2–6]. Its initia-
tion may be the result of inaccurate chromosomal segregation during
mitosis caused in part by defective telomere metabolism, centromere
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amplifications, dysfunctional centromeres, or defective spindle check-
point controls [7,8]. Centromere-driven CIN is resultant from a vari-
ety of insults to the centromere that impact in part or cumulatively on
the assembly of the kinetochore, segregation of the sister chromatids,
nuclear localization of centromeres, and recombination events at peri-
centromeric regions [9–11]. Pericentromeric regions are often hot-
spots for both recombination events during evolution [12] and in
cancer [10,13]. Centromere integrity is therefore essential for genomic
stability, and there are several examples where defects in centromere
function are associated with birth defects, spontaneously aborted fe-
tuses, Robertsonian (Rb) translocations, and cancers (for review, see
Gonçalves dos Santos Silva et al. [11]). In addition, pericentric inver-
sions in humans are often associated with decreased male fertility [14–
16], cancer [17–19], and mental retardation [20,21]. The centromeres
are also substrates for rearrangements that are associated with structural
genetic abnormalities in cancer where, in the same fashion as evolu-
tion, selection occurs at the cellular level in an accelerated manner
(for review, see Gonçalves dos Santos Silva et al. [11]).
Telomere dysfunction resulting from eroded or unprotected telo-
mere structures has been shown to induce CIN [22,23]. Unprotected
telomeres whether through erosion by progressive cell division or
telomere capping malfunction have been shown to recombine and il-
legitimately repair through the nonhomologous end joining double-
strand break repair pathway [24]. Such illegitimate telomeric repair is
known to generate telomere fusions and aggregates that form chro-
mosomal bridges leading to continued rounds of double-strand break
creation and mutational repair [25–28].
In melanoma, the possibility of correlating a specific pathological
stage with corresponding genetic alterations has allowed the experi-
mental study of different stages of tumor progression, but until now,
most experimental models of tumorigenesis use chemical or environ-
mental carcinogens and genetic manipulations to study the progres-
sion of this disease (for reviews, see Foijer et al. [29] and Wu and
Pandolfi [30]). Here, we used an experimental model of melanocyte
malignant transformation that uses forced sequential cycles of adhe-
sion blockage as a transforming factor in which the nontumorigenic
melanocyte lineage melan-a was cultured in suspension for 96 hours
[31]. Progressive morphologic alterations were observed along each
cycle of anchorage blockage culminating in the establishment of non-
tumorigenic melan-a sublines corresponding to intermediate phases
of malignant transformation found after two and four cycles of anchor-
age blockade (2C and 4C lineages, respectively). In addition, distinct
tumorigenic lineages, both slow-growing (4C3−) and fast-growing
melanoma lineages (4C3+) were established from spheroids formed
after a new anchorage blockade cycle of 4C cells. Oncogenic cell sig-
naling pathways generated through sequential anchorage blockage
cycles offer a novel opportunity to study the mechanisms for the de-
cline of genomic integrity specifically in melanoma. Our study sug-
gests that this transformation is driven by changes in telomere length
and stability, centromere stability, and overall karyotype evolution.
Materials and Methods
Cells and Cell Culture Conditions
The nontumorigenic murine melanocyte lineage, melan-a was grown
in RPMI (pH 6.9; Gibco, Carlsbad, CA), supplemented with 5% fetal
bovine serum (Gibco) and 200 nM 12-o-tetradecanoyl phorbol-13-
acetate (Tocris, Ellisville, MO) at 37°C in a humidified atmosphere
and 5% CO2. Melan-a cell sublines 2C, 4C, 4C3−, and 4C3+, es-
tablished after submitting melan-a cells to sequential substrate adhesion
impediment cycles, were cultured using the same conditions as the pa-
rental cell line but without the addition of 12-o-tetradecanoyl phorbol-
13-acetate. The melan-a cell line appears in this work as a near triploid
cell with a median of 54 chromosomes, which is probably a result of
the time in culture because this cell line has first been described as hav-
ing a normal diploid karyotype [32]. Cells were maintained at a density
of around 105 to 106 cells/ml.
Cell Fixation and Chromosome Preparations
Cells were harvested and spun down at 800 rpm for 10 minutes,
and for chromosome preparation, they were resuspended in 5 ml
of 0.075 M KCl for 30 minutes at room temperature. For chromo-
some fixation, the drop fixation method [33] was used. For the fixa-
tion of three-dimensional interphase nuclei, all cells were cultured on
glass slides until subconfluence and three-dimensionally fixed using
3.7% formaldehyde/phosphate-buffered saline for 15 minutes at
room temperature.
Immunofluorescence
Different cell lines were cultured on glass coverslips (Glasstécnica,
Sao Paulo, Brazil) until subconfluence and fixed in 1% paraformal-
dehyde in PBS. Fluorescent detection of c-Myc protein was performed
as described in Garagna et al. [34] by using a polyclonal anti–c-Myc
antibody (N262; Santa Cruz Biotechnology, Santa Cruz, CA) and a
goat antirabbit immunoglobulin G fluorescein isothiocyanate (FITC)
antibody, at 1:100 and 1:1000 dilutions, respectively. Analysis was per-
formed by using a Bio-Rad 1024 UV confocal system attached to a
Zeiss Axiovert 100 microscope (Carl Zeiss, Inc., Canada), with a
63×/1.4 oil objective lens.
Quantitative Fluorescence In Situ Hybridization
On slides with three-dimensional interphase nuclei fixed, telomere
fluorescence in situ hybridization (FISH) protocol was performed
as described above by using Cy3-labeled peptide nucleic acid (PNA)
probes (DAKO, Glostrup, Denmark). At least 30 nuclei were analyzed
for each cell line. AXIOVISION 4.6 (Carl Zeiss) with deconvolution
module was used. For every fluorochrome, the final three-dimensional
images consist of a stack of 50 individual images with a sampling dis-
tance of 200 nm along the z and 107 nm in the xy direction. Three-
dimensional image acquisition was performed on at least 30 nuclei
per cell line using an AxioImager Z1 microscope (Carl Zeiss) and an
AxioCam HR charge-coupled device (Carl Zeiss) with a 63×/1.4 oil
objective lens (Carl Zeiss). The constrained iterative algorithm was
used for deconvolution [35]. Note that telomeric signals at a distance
of 200 nm or less will be detected as one signal [36]. Telomere mea-
surements were done with TELOVIEW version 2.3 [37].
Fluorescent In Situ Hybridization
PNA-FISH was performed on two-dimensional metaphase samples
derived from T38Ha primary mouse fibroblasts, melan-a, 4C3−, and
4C3+. A Cy3-labeled PNA telomeric probe was purchased from
DAKO, and a PNA human centromeric probe (Applied Biosystems,
Foster City, CA) was custom-made. The sequences and the method
description were described elsewhere [38]. Additional FISH experi-
ments were performed using metaphase chromosomes of the 4C3− cell
line and a mouse pan-centromeric probe conjugated with FITC from
Cambio (Dry Drayton, Cambridge, UK). The experiment was carried
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out as described by Mai and Wiener [33]. All slides were imaged the
following morning to avoid changes in imaging conditions. Three-
dimensional image acquisition was performed on 20 metaphases per
sample using an Axioplan 2 microscope (Carl Zeiss) and an AxioCam
HR charge-coupled device (Carl Zeiss) with a 63×/1.4 oil objective
lens (Carl Zeiss).
Spectral Karyotyping Analysis
Spectral karyotyping (SKY) was performed using the ASI (Applied
Spectral Imaging, Vista, CA) kit for mice in accordance with the sup-
plier’s hybridization protocols. We used the Spectra Cube (ASI) on an
Axioplan 2 microscope (Carl Zeiss) with a 63×/1.4 oil objective and
the Case Data Manager 4.0 software (ASI) for PC to perform analyses.
A minimum of 20 metaphases was examined for each cell line.
Proliferation Rates Index – 3-(4,5-Dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium Bromide Assay
For measurements of cell viability, 2.5 × 103 cells/100 μl medium
were plated into each well of 96-well plates. After 24, 48, 72, or
96 hours of incubation, 10 μl of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium Bromide (MTT) solution (Calbiochem, Darm-
stadt, Germany) was added into each well, and plates were incubated
for 4 hours at 37°C, and 450 nm UV absorbance of each sample was
measured in a microplate reader. The assay was done in triplicate
wells, and P < .05 was considered significant.
Tumorigenicity Assay
Cells were harvested after trypsin treatment of subconfluent mono-
layers, counted, and then suspended in 1× PBS. Melan-a cells and
their derived clones (1 × 106 cells) were injected subcutaneously in
the flank of syngeneic 6- to 8-week-old C57Bl/6 female mice and de-
termined as follows: [maximum diameter × (minimum diameter)2] / 2.
Animals were kept under 12-hour daylight cycles, without food or
water restriction, and checked daily for tumor development. Each ex-
perimental group consisted of at least five animals (CEP 0738.07). The
P value for the overall study was less than .001.
Experimental Metastasis Assay
Cells of subconfluent cultures were trypsinized, suspended in RPMI
with 10% fetal calf serum, spin down, suspended in PBS, counted,
and adjusted to the necessary concentration. Cells (2 × 105) in 0.1 ml
of PBS were injected into the lateral tail vein of syngeneic C57BL/
6 female mice with a 27-gauge needle. Lungs were harvested 20, 40,
60, and 80 days later, and metastatic foci in the lungs were identified.
The experimental groups consisted of 15 animals for the 4C3− cell line
and 7 for the 4C3+ cell line.
Telomeric Repeat Amplification Protocol
Telomerase activity of cell lysates was analyzed by the telomeric
repeat amplification protocol assay with a TRAPeze Telomerase De-
tection Kit-S7700 (Chemicon, Millipore, Billerica, MA) according to
the manufacturer’s instructions. Each reaction was carried out by
using 0.05 μg of extract. Polymerase chain reaction (PCR) products
were electrophoresed in a 12.5% acrylamide gel (0.5 × TBE (Tris/
borate/EDTA) buffer using the PROTEAN II xi gel system (Biorad,
Hercules, CA). Gels were silver-stained according to the protocol de-
scribed elsewhere [39]. Images were captured by using FinePix S9000
digital camera (Fujifilm, Minato, Tokio, Japan).
Reverse Transcription–PCR
Total RNAwas isolated from cells with TRizol (Invitrogen, Carlsbad,
CA). One microgram of RNA was reverse-transcribed to complemen-
tary DNAwith Superscript III (Invitrogen). The resulting single-strand
complementary DNA were amplified by PCR in a reaction mixture
containing 75 mM Tris-HCl pH 9.0, 2 mM MgCl2, 50 mM KCl,
20 mM (NH4)2SO4, 0.4 mM of each deoxynucleotide triphosphate,
0.4 μM of each primer, 1 U of BioTools DNA Polymerase – recom-
binant from Thermus thermophilus (BioTools, Madrid, Spain). The
thermal cycling conditions were as follows: initial 5 minutes at 94°C,
followed by cycles (30 for Tert and 20 for β-actin amplifications) of
94°C for 45 seconds, 65°C for 45 seconds, and 72°C for 60 seconds.
The β-actin messenger RNA was used as control. PCR fragment am-
plification was confirmed by 1% agarose gel. The PCR primers were
as follows: Tert forward 5′CATGGGTGCCAAGTCCTGCTC3′; Tert
reverse 5′CTGTGCAGGCGGAGCAAATCC3′; actin forward 5′
CGAGGCCCAGAGCAAGAGAG3′; actin reverse 5′AGGAAGAG-
GATGCGGCAGTGG 3′.
Statistical Analysis
A Student’s t test with two tails was used to calculate the statistical
significance of the observed differences in telomere length. To calculate
the differences in c-Myc and Tert expression, the band intensities were
quantified using ImageJ 1.38 software (Image Processing and Analysis
in JAVA, Wayne Rasband, National Institutes of Health, Bethesda,
MD, http://rsb.info.nih.gov/ij/), and P values were determined by
one-way analysis of variance. To calculate the statistical significance
of the proliferation index and tumorigenesis assay, one-way analysis
of variance was used with Tukey’s post test. For the comparison of sur-
vival curves, log-rank test was performed. For chromosome rearrange-
ments and changes in ploidy, we used nonparametric Kruskal-Wallis
with Dunn’s post test. GraphPad Prism version 4.00 for Windows
(GraphPad Software, San Diego, CA, www.graphpad.com) was used
for the all calculations.
Results
Characterization of Our Mouse Melanoma Model
Cell viability and proliferation rates were characterized using the col-
orimetric MTT assay. The nontumorigenic cells (melan-a, 2C, and
4C) showed a similar in vitro proliferation rate. The tumorigenic cell
lines 4C3− and 4C3+ showed a higher proliferative ability than melan-a,
2C, and 4C (P < .0001; Figure 1A). All cell lines constitutively ex-
pressed c-Myc protein (Figure W2). Owing to these significant differ-
ences in the cell proliferation in vitro, we examined the consequences
of their different proliferation rates in vivo. As predicted and previously
described, melan-a, 2C, and 4C did not cause tumor formation
[31,40], whereas the injection of 4C3− cells led to tumor formation
with a growth rate roughly less than half of tumors produced by the
inoculation of 4C3+ cells (Figure 1B). In addition, the latency time
for tumor development after inoculation of the 4C3− cell line was
almost twice the time of 4C3+ being 25 and 14 days, respectively
(Figure 1C).
Next, we determined the metastatic capacity of 4C3− and 4C3+
cell lines. A total of 2 × 105 cells were inoculated intravenously, and
lungs were harvested 20, 40, 60, and 80 days later to check for meta-
static foci. After just 20 days, every animal that was inoculated with
4C3+ cell lines had several metastatic foci in their lungs (Figure 1D,
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white arrows). Conversely, metastatic foci were not found in the lungs
of animals that were inoculated with 4C3− cell line even 80 days
after injection (Figure 1, E–G ).
Telomere Shortening in the Presence of TERT Expression and
Telomerase Activity
To analyze the telomere length on our model, we performed quan-
titative FISH (Q-FISH) on three-dimensionally fixed interphase nuclei
with a Cy3 telomeric PNA probe. To this end, 30 nuclei were analyzed
per cell line. Telomere length progressively decreased through the mel-
anoma genesis model as illustrated by the column scatter graph in
Figure 2A. The immortalized cell line, melan-a, and the nontumori-
genic cell line (2C and 4C) showed highly heterogeneous telomeres
sizes, whereas we noted a smaller difference in size distribution in
the tumorigenic ones (4C3− and 4C3). In comparison to the parental
cell (melan-a), the variation in telomere length was very significant for
2C (P < .0005), significant for 4C (P < .009), and highly significant
for 4C3− and 4C3+ (P < .0001). In all cases, the differences in telo-
mere length with respect to the metastatic melanoma cell line (4C3+)
were highly significant (P < .0001).
The differences found in telomere length prompted us to analyze
the telomerase activity in the model (Figure 2B). Because the Tert
subunit seems to be the main rate-limiting determinant of telomerase
and it has been suggested to be an indicator of its activity [41,42], we
opted to analyze the expression of this gene by reverse transcription–
PCR. Tert was then quantified for all cell lines involved in this study,
and no statistical differences among the cells were found (Figure 2C ).
The loss of telomere-specific FISH signals was examined using the
telomere probe in metaphase spreads of primary cultures of mouse
T38Ha primary fibroblasts (used as a normal control—data not shown),
melan-a (data not shown), and on the nonmetastatic and metastatic
melanoma cell lines (4C3− and 4C3+, respectively; Figure 3).
All cell lines but the normal control displayedmarked loss of telomere-
specific signals, when compared with the control (P < .0001). The high-
est number of signal free ends was observed in 4C3+ where more than
30% of the ends had no distinguishable telomere signal (P < .001).
Whereasmelan-a showed telomere free ends on 9%of potential telomere
Figure 1. Characteristics of the mouse melanoma model. (A) Cell viability was determined by the MTT assay in triplicate. (B) Tumori-
genicity assay in vivo. Mice were subcutaneously injected with 2 × 105 cells. Bars: SD of the mean of five animals per group. ***P <
.0001. (C) Survival curves (100% × number of mice alive after each day / total number of mice at day 0) for mice inoculated with 4C3−
and 4C3+. Experimental metastasis assay: 2 × 105 4C3+ cells (D) and 4C3− (E, F, and G) were injected through the caudal vein. Mice
were killed 20 (D and E), 40 (F), and 80 (G) days later; their lungs were removed; and metastatic foci in the lungs were identified and some
are indicated in panel D by the white arrows. ma indicates melan-a cells; 2C and 4C, melan-a cells submitted to two and four substrate
adhesion blockade cycles, respectively; 4C3−, slow-growing melanoma cell line; 4C3+, fast-growing melanoma cell line.
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Figure 2. Shortening of telomeres in the presence of telomerase activity. (A) Telomere length distribution in the model as determined by
PNA telomere Q-FISH. The vertical lines and the arrows highlight the decreased heterogeneity of telomere lengths through the mela-
noma genesis model. (B) Telomerase activity in the model by the TRAP assay. (−) Non-heated extract, (+) heated extract, IC: internal
PCR control, C−: negative control and PD: primer dimers. (C) Tert expression analyzed in melan-a cells and melan-a–derived cell lines by
reverse transcription–PCR. β-Actin expression was used as a normalization control. No significant difference was observed between the
samples. ma indicates melan-a cells; 2C and 4C, melan-a cells submitted to two and four substrate adhesion blockade cycles, respec-
tively; 4C3−, slow-growing melanoma cell line; 4C3+, fast-growing melanoma cell line.
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signals (P < .05), the nonmetastatic cell line 4C3− showed telomere free
ends on 15% (P < .001). All together, these results indicate ongoing telo-
meric instability in this model.
Centromere Instability and Fragmentation
In our work, centromeric fragments were first observed by dual-color
FISH (Figure 3A) and by inverted 4′,6-diamidino-2-phenylindole dur-
ing the SKY analysis (Figure W1). To confirm these observations, a
mouse centromeric probe was then hybridized against the same slides
used for SKY. The centromere hybridization matched the structures
previously identified by inverted 4′,6-diamidino-2-phenylindole (Fig-
ure 4, A and B). The number of centromere fragments increased from
melan-a to 4C3, becoming negligible in 4C3+ (P < .0001; Figure 4C).
Some of the centromere fragments showed features of mini chro-
mosomes or double minutes containing four telomeric signals (Fig-
ure 3B). In addition, a nonrandom Rb translocation was noted in
4C3+ cells involving only chromosomes 8 and 12 (Table W1), sug-
gesting either nonrandom centromere instability or a selective prolif-
eration advantage of cells carrying this Rb chromosome combination
during the acquisition of metastatic potential.
Karyotype Evolution
Whereas the melan-a cell line displayed no structural aberrations
based on SKY analysis, the 2C, 4C, and 4C3− cell lines displayed
common structural aberrations of T(8;14), T(14;8), and Fus(8.6).
The metastatic melanoma cell line (4C3+) had a more heterogeneous
karyotype, indicative of higher instability in the latter cells. Support-
ing the case for increased genomic instability in the 43C+ cell line,
Rb fusions were found in 100% of metaphases analyzed from 4C3+
cells (Figures 5B and W1 and Table 1). Deletions of chromosome 11
were the only shared chromosomal abnormalities among 2C, 4C, 4C3−,
and 4C3+ cell lines (Table 1). Whereas the total number of chromo-
somes increased in the 4C3+ cell line to 72, the number of centromere
fragments decreased compared with all other cell lines. In contrast
to 4C3+, the 4C3− cell line showed on average fewer chromosomes,
53 per cell, with more centromere fragments (P < .0001; Table 1 and
Figure 4C).
Discussion
Our group has recently established a melanocyte malignant transfor-
mation model where a murine-nontumorigenic melanocyte cell line
(melan-a) was submitted to sequential cycles of cell anchorage block-
ade resulting in the establishment of nontumorigenic melan-a sublines
and several melanoma cell lines [31,40]. In melanoma, the possibility
of correlating a specific pathological state with several corresponding
genetic alterations has allowed the experimental study of different
stages of oncogenesis. Our cell adhesion blockage model allows for in-
vestigating early stage tumor progression unlike other chemical trans-
formation models or melanoma tissue samples.
Our results suggest that adhesion blockage cycles initiate telomere-
and centromere-driven CIN that becomes the causative factors in ge-
nomic instability and early tumor development. It is widely supported
that telomere dysfunction could play a causal role in early carcinogen-
esis by instigating bridge-breakage-fusion type chromosomal instabil-
ities, thus promoting neoplastic transformation [43,44].
To study the timing of the occurrence of telomere shortening during
melanocyte transformation, we analyzed in ourmodel the profile of telo-
mere length by Q-FISH. We found that telomere length significantly
Figure 3. Rb fusions and centromere abnormalities. Representative FISH images of 4C3− and 4C3+ metaphases hybridized with probes
against centromere and telomere. 4C3− cell line is shown in panels A, B, and C. Note the centromere fragment in the magnification box;
it shows under the centromere staining (A) four telomeric signals (B) and the merge image (C). (D, E, and F) Representative metaphase
of the 4C3+ cell line. Rb fusion is shown on the magnification boxes. Note that under the centromeric fusion point (D), there are no
telomeric signals (E). (A and D) Centromeric signals only. (B and E) Telomeric signals only. Note that in both cell lines, chromosomes
with missing signals are present, but 4C3+ had the highest percentage of telomere free ends (see text). 4C3− indicates slow-growing
melanoma cell line; 4C3+, fast-growing melanoma cell line.
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decreased as additional rounds of cell anchorage blockages were per-
formed. In addition, variation among telomere length for individual
cell lines significantly decreased in parallel with telomere length as
subsequent cell anchorage blockages were performed. The develop-
ment of smaller and less variable sized telomeres is described in a
multitude of cancers [45]. These findings are in agreement with the
idea that telomere length abnormalities seem to be one of the ear-
liest genetic alterations acquired in the multistep process of malig-
nant transformation.
Figure 4. Centromere fragments. Multicentric chromosomes and
centromere fragments are visible by FISH. Metaphases of 4C3−
cell line were hybridized using a mouse pan-centromeric probe
conjugated to FITC (green) (Cambio). (A) Inverted DAPI image.
(B) Pan-centromeric probe. White squares highlight the centro-
mere fragments, and they are shown on the magnification boxes
in both panels. (C) Number of centromere fragments in all the cell
lines. Note that the numbers increased from melan-a to 4C3−, al-
most disappearing on 4C3+. 4C3− indicates slow-growing mela-
noma cell line; 4C3+, fast-growing melanoma cell line.
Figure 5. Chromosome rearrangements. A total of 20 metaphases
were examined for each cell line. (A) Number of rearrangements
found in each cell line per metaphase. (B) Number of Rb chromo-
some found per metaphase in the melanoma model. (C) Variation
in ploidy found in the tumorigenesis model.
Table 1. Summary of the Rearrangements Found throughout Melanocyte Malignant Transformation.
Cell Line No. Chromosomes* Centromere Fragments† Aberration Chart (Structural Aberrations)
melan-a 54 Yes {1} None
2C 51 Yes {1} T(8;14){13}/T(14;8){20}/F(8;6){19}/Del(11){18}
4C 51 Yes {1} T(8;14){19}/T(14;8){21}/T(15;X){18}/F(8;6){4}/Del(11){18}
4C3− 53 Yes {2} T(8;14){18}/T(14;8){21}/T(5;18){9}/T(15;X){18}/F(8;6){15}/Del(11){17}
4C3+ 72 None {0} T(1;16){18}/T(8;1){17}/T(1;12){15}/T(3;13){20}/T(13;3){20}/T(X;15){19}/
T(10;16){16}/Rb(8.12){15}/Rb(12.12){26}/Del(1){18}/Del(6){12}/Del(11){20}
The data given are derived from the analysis of 20 metaphases. The braces indicate how often each rearrangement was seen in 20 metaphases. Only rearrangements that were present in more than 2
metaphases are presented here.
*Median of chromosome number from 20 metaphases.
†Absence or presence of centromere fragments in the metaphases; braces represent the median of fragments found in the cell lines studied.
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Indeed, telomere shortening and telomerase activation are the
most prevalent aberrations in precancerous lesions [46]. Telomere
length abnormalities have been described in preinvasive breast lesions
[47], pancreas [48], prostate [49–51], and many different types of
human epithelial cancer precursor stages [52]. Likewise, telomerase
activity has been detected early in carcinogenesis [53–55].
In addition, an in vivo study in human breast cancer found that
cancer cells continue to experience telomere loss and anaphase bridges
even after the expression of telomerase [56]. These data suggest that
telomerase expression alone is not sufficient to maintain telomeres at
noncritical length. Similarly, in our mouse melanoma model, we ob-
served telomere shortening in parallel to genomic instability in the
context of telomerase-positive cell lines. In addition, several lines of
evidence suggest a protective function for telomerase apart from its role
in telomere elongation [57,58]. In recent work, Xu and Blackburn
[59] described a distinct class of extremely short telomeres (t-stumps)
in human cancer cells with active telomerase.
Apart from telomere abnormalities, our melanoma displays an abun-
dance of centromeric instability manifested as centromere fragments
and centromeric fusions. Those centromere fragments increase from
melan-a to 4C3− almost disappearing in 4C3+ where the Rb fusions
are present. Many centromeric fragments contained four telomere sig-
nals and could be described as mini chromosomes or double minutes.
These structures were likely produced by the fusion of two individual
centromere fragments where the shortening of telomeres would lead to
a telocentric fusion creating two chromosomes with terminal deletions
and one centromere fragment with four telomeric signals. This mech-
anism is supported by the fact that the rate of telomere free ends in-
creases as additional rounds of cell adhesion blockages are performed.
Rb translocations in humans constitute the most common struc-
tural genetic abnormalities in aborted fetuses and newborns [60–62].
Moreover, human Rb translocation chromosomes have been found as
acquired or constitutional genetic lesions in hematological cancers
[63,64] in solid tumors [65,66] and at the onset of acute myeloge-
nous leukemia [67]. The presence of Rb fusions in our model corre-
lates with oncogenesis because the metastatic cell line is the only cell
line with the Rb structure.
Our results describe a melanoma model whereby repetitive cycles of
cell anchorage blockage generate CIN with a cytological signature of
centromere breakage and telomeric loss. This phenotype in immortal-
ized melanocyte melan-a cells that seem to have initial genomic or epi-
genomic insults. This unique model allows for molecular investigations
into the early stages of development for melanoma.
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Figure W1. Karyotype evolution. SKY of metaphases derived from cell lines corresponding to phases of melanocyte malignant trans-
formation. Representative images from SKY are shown: (A) melan-a, (B) 2C, (C) 4C, (D) 4C3−, and (E) 4C3+. White arrows point to Rb
fusion chromosomes. Note the increase of abnormalities through the model and the increase of chromosome number in the 4C3+ cell
line. Each panel shows a representative image for each cell type; however, the layout is the same for all. Left panel: the raw image of a
metaphase; central panel: the classified image of the metaphase; right panel: the inverted DAPI-banded image of the metaphase; and
larger panel: the karyotype table of the metaphase. ma indicates melan-a cells; 2C and 4C, melan-a cells submitted to two and four
substrate adhesion blockade cycles, respectively; 4C3−, slow-growing melanoma cell line; 4C3+, fast-growing melanoma cell line.
Figure W1. (continued).
Figure W2. Indirect immunofluorescence using a c-Myc–specific antibody. c-Myc staining in the melanoma model. Each panel shows a
representative image for each cell type; however, the layout is kept constant. Left column: c-Myc staining (N262; Santa Cruz Biotech-
nology); central column: nuclear staining (DAPI); right column: merge images. ma indicates melan-a cells; 2C and 4C, melan-a cells sub-
mitted to two and four substrate adhesion blockade cycles, respectively; 4C3−, slow-growing melanoma cell line; 4C3+, fast-growing
melanoma cell line. Bars, 20 μm.
Table W1. Summary of Chromosomes Involved in the Formation of Rb Chromosomes in 4C3+
Cells in a Nonrandom Manner.
Chromosome Number Times Involved in Rb Fusions P
8 15 <.01
12 67 <.001
The numbers given are derived from the analysis of 20 metaphases. All metaphases carried at least one
Rb chromosome, fifteen of these 20 metaphases carried two or more Rb fusions. The involvement of
each chromosome in the formation of Rb chromosomes is given, and the respective significance is
indicated. Fifteen of twenty metaphases (75%) carried one Rb fusion involving chromosomes 8 and
12, whereas 100% of the metaphases analyzed carried at least one Rb(12.12). For further details, see
text and Materials and Methods section.
